Turkish Thoracic Journal
Case report

Primary Pulmonary Marginal Cell Lymphoma: Your Eyes See Only What Your Mind Knows

1.

Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India

2.

Department of Pathology and Lab Medicine, AIIMS, Bhopal, Madhya Pradesh, India

3.

Department of Pathology, Tata Memorial Hospital, Mumbai, Maharashtra, India

Turk Thorac J 2021; 22: 271-273
DOI: 10.5152/TurkThoracJ.2021.20008
Read: 78 Downloads: 14 Published: 03 June 2021

Lung cancer is the leading cause of cancer-associated mortality, with a 5-year survival of 19% for all types of lung cancer. Lymphoid malignancies of the lung have a significantly better prognosis, with 5-year survival approaching 90%, making it very important to identify these patients. As the signs and symptoms, laboratory investigations, and radiological features are non-specific and vague and the histological confirmation is invasive, they are usually either not diagnosed or diagnosed very late. We present a case of an elderly male who was treated for months with antituberculosis treatment (ATT) before being properly evaluated and diagnosed with primary pulmonary marginal cell lymphoma. This case was unique for having gross pleural effusion as a presenting feature and having been diagnosed with the help of radial endobronchial ultrasound (EBUS).

Cite this article as: Hussain A, Soman R, Goyal A, et al. Primary pulmonary marginal cell lymphoma: Your eyes see only what your mind knows. Turk Thorac J. 2021; 22(3): 271-273.

Files
EISSN 2149-2530